Utilidad clínica de la determinación de beta-2-microglobulina

Medicina Clinica

Volumn 106, Issue 19, 1996, Pages 751-755

  Gazapo, E ^a   Gazapo, R M ^b   Caturla, A ^b  

^a ABBOTT LABORATORIES   (Spain)

^b Fund Jiménez Díaz

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ARTICLE; DIAGNOSIS; HUMAN;

BETA 2-MICROGLOBULIN; DIAGNOSIS; HUMANS;

EID: 0030592065     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. 2-microglobulin in clinical medicine. Scand J Clin Lab Invest 1990, (Supl 154) 40: 27-37
2. Viberti GC, Keen H, Mackintosh D Beta-2-microglobulinemia: a sensitive index of diminishing renal function in diabetics Br Med J Clin Res (Edimburgo) 1981; 282: 95-98.
3. 2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol 1984, 32 174-184.
4. 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol 1984, 37: 1 140-1.143
5. 2-microglobulin A new marker of activity in Crohn's disease. N Engl J Med 1979; 301: 440-441
6. 2-microglobulin plasma levels reflect disease activityin reumatoid arthritis. J Reumathol 1983; 10 954-956
7. 2-microglobulin. A tumor marker of lymphocyte disorder Lancet 1978; 2: 950.
8. Bataille R, Dune BG, Grenier J, Sany J Prognostic factors and staging in multiple myeloma a reappraisal. J Clin Oncol 1986; 4 80-87
9. 2-globulin occurring in human biological fluids. J Biol Chem 1968; 243: 4 095-4.103
10. 2-microglobulin J Exp Med 1973, 138 1.608-1 612.
11. 2-microglobulin and the common portion fragment derived from HLA antigen moleculares. Proc Natl Acad Sci USA 1973; 70: 2 863-2865
12. 2-microglobulin- A free immunoglobulin domain Proc Natl Acad Sci USA 1972, 69 1 967-1.701.
13. 2-microglobulin: Structure, function and significance. Vox Sang 1980; 38: 323-327
14. 2-microglobulin and immunodeficiency in homosexual man. N Engl J Med 1982; 307. 1.402-1.403.
15. Radkowsky M, Laskus T, Kopicz-Kaminska E, Mian M, Babiuch L, Slusarczyk J Prospective studies of T4 and T8 lymphocyte subpopulations and beta-2-microglobulin in patients with HIV infection Pol Arch Med Wewn 1991; 86. 247-253.
16. Sirivichayakul S, Phanuphak P, Hanvanich M, Ruxrunghtam K, Panmoung W, Thanyanon W. Clinical correlation of the immunological markers of HIV infection in individuals from Thailand AIDS 1992, 6: 393-397
17. 2-microglobulin in HIV infection. Lancet 1992; 340. 370-371
18. 2-microglobulin relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection. Enferm Infec Microbiol Clin 1993; 11: 373-377
19. Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev 1994; 7: 14-28.
20. Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barhart L, Segal M et al. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection Lancet 1992; 339: 1 436-1.440
21. 2-microglobulin levels and HIV status in Romanian orphanage children. Wien Klin Wochenschr 1993, 105: 284-288.
22. Chaisson RE, Taylor E, Margolick JB, Muñoz A, Solomon L, Cohn S et al. Immune serum and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr 1992; 5: 456-460
23. Serra JE, Pombo V, Corte-Real R, Da Cunha S, Mehco-Silvestre A. Comparative study of various biological markers in HIV-1 infection Acta Med Port 1993; 6: 5-9.
24. Richard L, Pellegrin JL, Barbeau P, Brassard G, Leng B, Fleury HJ. HIV-1 and HCV co-infected patients- detection of active viral expression using a nested polymerase chain reaction Mol Cell Probes 1993; 7: 405-410.
25. 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up. Clin Chem 1988; 34: 1.367-1.368.
26. Dolan MJ, Lucey DR, Hendrix CW, Melcher GP, Spencer GA, Boswell RN Early markers of HIV infection and subclinical disease progression. Vaccine 1993, 11: 548-551.
27. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of person with syncytium-and non-syncytium-inducing human immunodeficiency virus J Infect Dis 1993; 168: 1.374-1.379.
28. 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate The Multicentre Cohort Study Group. AIDS 1993, 7: 813-821.
29. Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E et al Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS 1992; 6: 685-689.
30. Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Moulton LH et al. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil, impact on markers of HIV disease progression JAMA 1994; 271. 353-357.
31. Volberding PA. HIV, HTLV-I and CD4+ lymphocytes Troubles in the relationship [editorial]. JAMA 1994, 271: 392-393.
32. Lange JMA, De Wolf F, Goudsmith J. Markers for progression in HIV infection. AIDS 1989; 3 (Supl 1). 153-160.
33. 2-microglobulin in HIV-1-seronegative meeting drug users. AIDS 1993; 7: 361-367.
34. 2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection Enferm Infecc Microbiol Clin 1993; 11. 373-377.
35. 2-microglobulin levels in mildty symptomatic, HIV type 1 seropositive individuals J Acquir Immune Defic Syndr 1992; 5: 215-221.
36. 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers of vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993; 7: 1.475-1.479.
37. Luke DR, Sarnoski TP, Dennis S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol 1992; 38. 69-74.
38. Meillet D, Hoang PL, Unanue F, Kapel N, Diemert MC, Rousselie F et al. Filtration and local synthesis of lacrimal proteins in acquired immunodeficiency syndrome. Eur J Clin Chem Clin Biochem 1992; 30: 319-323.
39. Di Perri G, Micciolo R, Vento S, Cruciani M, Marocco S, Carlotto A et al. Risk of reactivation of tuberculosis in the course of human immunodeficience virus infection Eur J Med 1993; 2: 264-268.
40. 2-microglobuline in HIV-1-associated tuberculosis J Infect Dis 1993; 167 43-48.
41. Smith JR, Kitchen VS, Botcherby M, Hepburn M, Wells C, Gor D et al Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet 1993, 100: 149-153.
42. 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 1992, 42: 1.707-1.712
43. 2-microglobulin and lysozyme differential markers of nervous system involvement in patients infected with human immunodeficiency virus type 1. Eur J Clin Chem Clin Biochem 1993; 31: 609-615.
44. 2-microglobulin in patients with AIDS dementia complex an expanded series including response to zidovudine treatment AIDS 1992; 6. 461-465.
45. Gulevich SJ, McCutchan JA, Thal LJ, Kirson D, Durand D, Wallace M et al. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus J Acquir Immune Defic Syndr 1993; 6: 1 002-1 007
46. Tyor VR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L et al Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992; 31. 349-360.
47. 2-microglobulin in HIV-1 infection, as a marker of neurological involvement. Neural Red 1991; 13: 131-132
48. Pepin J, Morgan G, Dunn D, Gevao S, Mendy M, Gaye I et al HIV-2-induced immunosuppression among asymptomatic West African prostitutes. evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 1991; 5: 1.165-1.172
49. Aurelius E, Forsgren M, Skoldenberg B, Strannegard O. Persistent intrathecal immune activation in patients with herpes simplex encephalitis J Infect Dis 1993; 168: 1.248-1 252.
50. Simeone U, Schnitzler B, Massfelder T, Hirt C, Koehl C, Hamel G et al Specific developmental profiles of lysosomal and brush border enzymuria in the human Biol Neonate 1994; 65. 1-6
51. 2-microglobulin and microalbuminuria in familial Mediterranean fever. Arch Dis Child 1994; 70: 27-29.
52. 2-microglobulin concentration in dialysis patients. importance of intrinsic renal function. J Lab Clin Med 1994; 123: 495-505
53. Stefanovic V, Kostic S, Djordjevic V, Mitic M, Bogicevic M. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy. Perit Dial Int 1993; 13 (Supl 2): 520-522.
54. 2-microglobulin (B2MG) in blood serum of patients during the early phase after kidney transplantation Pol Arch Med Wewn 1993; 90: 254-259.
55. 2-microglobulin (B2MG) in blood serum of patients during the early phase after kidney transplantation Pol Arch Med Wewn 1993, 90. 254-259
56. Turner G, Coates P, Porter S, Peters JR, Woodhead JS Urinary growth hormone measurements as a marker of renal tubular function in diabetes mellitus. Clin Chim Acta 1993; 220: 19-30.
57. De-Marchi S, Cecchin E, Basile A, Bartotti A, Nardini R, Bartoli E, Renal tubular dysfunction in chronic alcohol abuse effects of abstinence. N Engl J Med 1993; 329: 1.927-1.934.
58. Chen MR, Lin JL, Liaw SJ, Bullard MJ. Acute iron intoxication, a case report with ferric chloride ingestion. Chung Hua I Huseh Tsa Chih Taipei 1993; 52: 269-272.
59. Cornelissen JJ, Sonneveld P, Schoester M, Raajimakers HG, Nieuwenhuis HK, Dekker AW et al. MDR-1 expression and response to vincristine, doxorubicin and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents. J Clin Oncol 1994, 12: 115-119.
60. Tsuntani I, Honda R, Ishizaki M, Yamada Y, Aoshima K, Kasuya M. Serum bone-type alkaline phosphatase activity in women living in a cadmium-polluted area. Toxicol Lett 1994; 71: 209-216.
61. 2-microglobulin concentration and mortality in a cadmium-polluted area. Arch Environ Health 1993, 48. 428-435.
62. Lipitz S, Ryan G, Samuell C, Haausler MC, Robson SC, Dhillon HK et al. Fetal urine analysis for the assessment of renal function in obstructive uropathy. Am J Obstet Gynecol 1993; 168: 428-435
63. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Pereira AB. Renal abnormalities in leprosy. Nephron 1993; 65 381-384
64. Kile RA. Newer approaches to the management of multiple myeloma. Cancer 1993; 72 (Supl 11): 3.489-3.494.
65. Kozawa M, Hata H, Kawaguchi T, Tsuji N, Mon S, Harada N et al. Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion. Rinsho Ketsueki 1994; 35: 49-53.
66. Ballester OF, Moscinski LC, Lyman GH, Chaney JV, Saba HI, Spiers AS et al. High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. Blood 1994; 83: 1.903-1908.
67. Omede P, Boccadoro M, Fusaro A, Gallone G. Pileri A. Multiple myeloma: «early» plasma cell phenotype identifies patients with aggressive biological and clinical characteristic. Br J Haematol 1993; 85: 504-513.
68. 2-microglobulin and thymidine kinase. Clin Invest 1993; 71: 918-923.
69. Johnson PW, Whelan J, Longhurst S, Stepmewska K, Matthews J, Amess J et al. Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. Br J Cancer 1993, 67: 792-797.
70. 2-microglobulin as an indicator of early relapse in diffuse large cell lymphoma. Leuk Lymphoma 1993; 9 377-380.
71. 2-microglobulin in Hodgkin's disease. J Clin Oncol 1993; 11. 1.108-1.111.
72. Pugima SA, Vorob'ev VG. The cytological and biochemical aspects of studying the cerebrospinal fluid in patients with chronic myeloleukemia. Ter Arkh 1993, 65. 33-37.
73. 2-microglobulin and SLE. Arthritis Rheum 1976; 19: 968
74. 2-microglobulin Sjögren syndrome. Scand J Rheumatol 1978; 7: 97-100.
75. Verburgh CA, Hart MH, Aarden LA, Swaak AJ. Interleukin-8 (LL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clin Rheumatol 1993; 12: 494-499.
76. 2-microglobulin levels in serum and saliva of patients with juvenile periodontitis. J Nihon Univ Sch Dent 1993; 35: 230-234.
77. 2-microglobulin concentrations in hyperthyroid states. J Clin Pathol 1991; 44: 73-74.
78. Rico H, Ripoll E, Revilla M, Relea P, Villa LF. Beta 2-microglobulin in postmensual osteoporosis. Calcif Tissue Int 1993; 53: 78-80.